Atlas Molecular Pharma

About:

Atlas Molecular Pharma is focused on the discovery of first-in-class, innovative therapeutics for the treatment of patients.

Website: https://atlasmolecularpharma.com/

Twitter/X: atlasmolecular

Top Investors: Inveready, CDTI, Kereon Partners, Ezten Venture Capital Fund

Description:

Atlas Molecular Pharma is focused on the discovery of first-in-class, innovative therapeutics for the treatment of patients suffering from Rare and Ultra-Rare Diseases. Its line of work focuses on the development of a proprietary technology that enables the identification of molecules / drugs that provide stability to certain proteins whose dysfunction is responsible for the development of a large part of these rare diseases.

Total Funding Amount:

3M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Derio, Pais Vasco, Spain

Founded Date:

2015-01-01

Contact Email:

info(AT)atlasmolecularpharma.com

Founders:

Oscar Millet

Number of Employees:

1-10

Last Funding Date:

2022-02-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai